shafi_banner

3415-08-5 L-Tyr-NCA

3415-08-5 L-Tyr-NCA

Takaitaccen Bayani:

Bayyanar Fari zuwa Kashe-Farin lu'ulu'u ko foda mai lu'ulu'u
MF Saukewa: C10H9NO4
MW 207.18
Tsafta 98+


Cikakken Bayani

Yanayin sufuri&hanyar jigilar kayayyaki da aka ba da shawarar:
ta iska, ta ruwa ko ta hanyar bayyanawa

Yanayin ajiya:
yanayi nert, Ajiye a cikin injin daskarewa, ƙasa da -20 ° C

Mafi ƙarancin oda Qty:
Tattaunawa

Takaddun shaida:
COA, HPLC, GC, HNMR, Assay, Abubuwan Ruwa (KF), TLC akwai

D-Lys(tfa) -NCA (2)

Makamantu

Tyrosine, NCA;

N-Carboxy-L-tyrosine anhydride;

(4S) -4- [(4-Hydroxyphenyl) methyl] -2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl] -, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

Packing na ciki

Yawancin lokaci ana amfani da su don shirya foda.Kuma za su iya hana rana da ruwa yin muni.

Shirye-shiryen ciki 2
Shirye-shiryen ciki 1
Shirye-shiryen ciki 3

shiryawa na waje

Katin mai wuya zai iya kare samfuran ku daga faɗuwa da jika.

Shirye-shiryen waje 3
Shirye-shiryen waje 2
Shirye-shiryen waje 1

Aikace-aikace

3415-08-5 L-Tyr-NCA yana ɗaya daga cikin tsaka-tsakin Glatiramer Acetate.

Glatiramer Acetate wakili ne na peptide da aka shirya wanda ya ƙunshi amino acid guda huɗu: glutamic acid, alanine, tyrosine, da lysine.Babban aikace-aikacen sa yana cikin maganin Multiple Sclerosis (MS), cuta mai lalacewa, mai kumburi, cutar da ke shafar tsarin juyayi na tsakiya.Ta hanyar hanyar "cirewa ta hanyar wucewa," Glatiramer Acetate yana haifar da immunomodulatory da anti-inflammatory effects a cikin MS, yana kara yawan matakan da ake samu na neurotrophic factor (BDNF), ƙaddamar da ƙaddamar da ƙwayar cuta, da kuma inganta ci gaban axon da myelin sheaths.

A duk duniya, Glatiramer Acetate ya sami aikace-aikacen tartsatsi.Alal misali, a Amurka, ana sayar da shi a ƙarƙashin sunan alamar Copaxone kuma Hukumar Abinci da Magunguna (FDA) ta amince da ita don maganin Sclerosis da yawa.A cikin ƙasashen Yamma masu yawan yaɗuwar MS, an san ingancinsa da juriyarsa sosai.

A kasar Sin, a ranar 28 ga Yuni, 2023, "Glatiramer Acetate Injection" a hukumance ta sami izini daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta Kasa (NMPA) don kula da manya masu fama da relapsing-remitting Multiple Sclerosis (MS), gami da keɓantaccen ciwo na asibiti, mai sake dawowa. MS, da kuma MS mai ci gaba na sakandare mai aiki.

samfurori masu dangantaka

L-Gly-NCA L-Ala-NCA D-Ala-NCA L-Val-NCA
D-Leu-NCA DL-Lu-NCA L-Phe-NCA D-Tyr-NCA
L-Tyr (bzl) -NCA L-Glu(Obzl) -NCA D-Asp(OBzl) -NCA L-Lys(tfa) -NCA
L-Lys (Cbz) -NCA D-Lys (Cbz) - NCA Sar-NCA

fifiko

1. Akwai sabis na R&D
2. ISO bokan manufacturer, ingancin garanti
3.A cikakken hanya na biyan sabis a lokacin samarwa
4.High kudin tasiri
5.Quality takaddun takaddun shaida da aka bayar ta buƙatar abokin ciniki
6.Great bayan-tallace-tallace da sabis, rike kusa da dangantaka da abokin ciniki
7.Full albarkatun don taimakawa rage farashin kaya
8.Free samfurin da aka ba don duba inganci kafin kowane biyan kuɗi
9.Biyan kuɗi ya yi shawarwari
10.Assit abokan ciniki kula da al'amura a kasar Sin


  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana